🎉 M&A multiples are live!
Check it out!

Novanta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Novanta and similar public comparables like Myomo, Philips, and InfuSystem.

Novanta Overview

About Novanta

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.


Founded

1970

HQ

United States of America
Employees

3K+

Website

novanta.com

Financials

LTM Revenue $970M

LTM EBITDA $221M

EV

$4.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Novanta Financials

As of September 2025, Novanta reported last 12-month revenue of $970M and EBITDA of $221M.

In the same period, Novanta generated $440M in LTM gross profit and $62.5M in net income.

See Novanta valuation multiples based on analyst estimates

Novanta P&L

In the most recent fiscal year, Novanta reported revenue of $949M and EBITDA of $180M.

Novanta expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Novanta valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $970M XXX $949M XXX XXX XXX
Gross Profit $440M XXX $422M XXX XXX XXX
Gross Margin 45% XXX 44% XXX XXX XXX
EBITDA $221M XXX $180M XXX XXX XXX
EBITDA Margin 23% XXX 19% XXX XXX XXX
EBIT $172M XXX $124M XXX XXX XXX
EBIT Margin 18% XXX 13% XXX XXX XXX
Net Profit $62.5M XXX $64.1M XXX XXX XXX
Net Margin 6% XXX 7% XXX XXX XXX
Net Debt XXX XXX $303M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Novanta Stock Performance

Novanta has current market cap of $3.8B, and EV of $4.2B.

Market Cap Evolution

Novanta Stock Data

As of October 17, 2025, Novanta's stock price is $106.

See Novanta trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.2B $3.8B XXX XXX XXX XXX $3.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Novanta Valuation Multiples

Novanta's trades at 4.4x EV/Revenue multiple, and 23.4x EV/EBITDA.

See valuation multiples for Novanta and 15K+ public comps

Novanta Financial Valuation Multiples

As of October 17, 2025, Novanta has market cap of $3.8B and EV of $4.2B.

Equity research analysts estimate Novanta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Novanta has a P/E ratio of 60.7x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $3.8B XXX $3.8B XXX XXX XXX
EV (current) $4.2B XXX $4.2B XXX XXX XXX
EV/Revenue 4.3x XXX 4.4x XXX XXX XXX
EV/EBITDA 19.0x XXX 23.4x XXX XXX XXX
EV/EBIT 24.4x XXX 33.8x XXX XXX XXX
EV/Gross Profit 9.5x XXX n/a XXX XXX XXX
P/E 60.7x XXX 59.3x XXX XXX XXX
EV/FCF 31.5x XXX 29.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Novanta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Novanta Margins & Growth Rates

Novanta's last 12 month revenue growth is 6%

Novanta's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Novanta's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Novanta's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Novanta and other 15K+ public comps

Novanta Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 6% XXX 5% XXX XXX XXX
EBITDA Margin 23% XXX 19% XXX XXX XXX
EBITDA Growth 10% XXX 15% XXX XXX XXX
Rule of 40 26% XXX 25% XXX XXX XXX
Bessemer Rule of X XXX XXX 38% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 10% XXX XXX XXX
Opex to Revenue XXX XXX 31% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Novanta Public Comps

See public comps and valuation multiples for Medical Devices and Robotics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Novanta M&A and Investment Activity

Novanta acquired  XXX companies to date.

Last acquisition by Novanta was  XXXXXXXX, XXXXX XXXXX XXXXXX . Novanta acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Novanta

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Novanta

When was Novanta founded? Novanta was founded in 1970.
Where is Novanta headquartered? Novanta is headquartered in United States of America.
How many employees does Novanta have? As of today, Novanta has 3K+ employees.
Who is the CEO of Novanta? Novanta's CEO is Mr. Matthijs Glastra.
Is Novanta publicy listed? Yes, Novanta is a public company listed on NAS.
What is the stock symbol of Novanta? Novanta trades under NOVT ticker.
When did Novanta go public? Novanta went public in 1999.
Who are competitors of Novanta? Similar companies to Novanta include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Novanta? Novanta's current market cap is $3.8B
What is the current revenue of Novanta? Novanta's last 12 months revenue is $970M.
What is the current revenue growth of Novanta? Novanta revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Novanta? Current revenue multiple of Novanta is 4.3x.
Is Novanta profitable? Yes, Novanta is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Novanta? Novanta's last 12 months EBITDA is $221M.
What is Novanta's EBITDA margin? Novanta's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Novanta? Current EBITDA multiple of Novanta is 19.0x.
What is the current FCF of Novanta? Novanta's last 12 months FCF is $133M.
What is Novanta's FCF margin? Novanta's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Novanta? Current FCF multiple of Novanta is 31.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.